<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04977362</url>
  </required_header>
  <id_info>
    <org_study_id>1564/108</org_study_id>
    <nct_id>NCT04977362</nct_id>
  </id_info>
  <brief_title>Interdisciplinary Perioperative Care in Minimally-invasive Heart Valve Surgery</brief_title>
  <acronym>INCREASE</acronym>
  <official_title>Interdisciplinary and Cross-sectoral Perioperative Care Model in the Cardiac Surgery: Implementation in the Setting of Minimally-invasive Heart Valve Surgery (INCREASE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BARMER</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Augsburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Valvular heart diseases are among the most common cardiac pathologies in adult patients in&#xD;
      Germany. Currently, the process of care before, during and after heart valve surgery does not&#xD;
      follow a standardized and interdisciplinary optimal approach. An approach already established&#xD;
      in other surgical disciplines is the Enhanced Recovery After Surgery (ERAS) protocol, which&#xD;
      aims at optimizing the recovery process of patients. Within the INCREASE study, a care&#xD;
      process inspired by the ERAS protocol will be established at the University Heart and&#xD;
      Vascular Center (UHZ) of the University Medical Center Hamburg-Eppendorf (UKE) and the&#xD;
      University Medical Center Augsburg (UKA). Executing the study at two facilities in different&#xD;
      regions in Germany will help to demonstrate transferability of the process of care. The&#xD;
      effectiveness of this process compared to the current treatment approach will be investigated&#xD;
      in a randomized controlled trial. A total of 186 patients will be allocated by chance either&#xD;
      to the intervention group (ERAS protocol) or the control group (treatment as usual). Patients&#xD;
      in the intervention group will receive an optimized interdisciplinary care protocol including&#xD;
      medical, nursing, physiotherapeutical and psychotherapeutical interventions. Measurements of&#xD;
      effectiveness are the number of hospitalized days (due to cardiac causes) within one year and&#xD;
      the physical condition of the patient as measured by the 6-minute walk test (6MWT) on the day&#xD;
      of discharge.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Controlled Trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>All scientists and statisticans involved in the analysis of the study will be blinded to the allocation of participants and will receive only pseudomized data from the study coordinator, who organises data collection.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Hospitalization</measure>
    <time_frame>twelve months</time_frame>
    <description>number of hospitalized days due to cardiac reasons</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Six Minute Walk Test</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>physical capacity expressed with the walking distance in meters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Goal Attainment Scale (GAS)</measure>
    <time_frame>three months</time_frame>
    <description>level of attainment of individual goal:&#xD;
2 = much more than expected&#xD;
1 = somewhat more than expected 0 = goal achieved than expected&#xD;
1 = somewhat less than expected&#xD;
2 = much less than expected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Goal Attainment Scale (GAS)</measure>
    <time_frame>twelve months</time_frame>
    <description>level of attainment of individual goal:&#xD;
2 = much more than expected&#xD;
1 = somewhat more than expected 0 = goal achieved than expected&#xD;
1 = somewhat less than expected&#xD;
2 = much less than expected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Form 12 (SF 12)</measure>
    <time_frame>three months</time_frame>
    <description>quality of life; 12 items, min 0, max 100, mean score is set to 50, higher scores indicating better health than mean</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Form 12 (SF 12)</measure>
    <time_frame>twelve months</time_frame>
    <description>uality of life; 12 items, min 0, max 100, mean score is set to 50, higher scores indicating better health than mean</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs</measure>
    <time_frame>up to 10 days</time_frame>
    <description>direct costs in € associated with the operative procedure and the initial hospitalization using diagnosis related groups as classification system, in which diagnoses and treatments are valued according to their necessary economical expenditure</description>
  </secondary_outcome>
  <other_outcome>
    <measure>European Health Literacy Questionnaire (HLS-EU-Q16)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>health literacy: 16 items, min 16, max 64, higher scores indicating lower health literacy</description>
  </other_outcome>
  <other_outcome>
    <measure>European Health Literacy Questionnaire (HLS-EU-Q16)</measure>
    <time_frame>twelve months</time_frame>
    <description>health literacy: 16 items, min 16, max 64, higher scores indicating lower health literacy</description>
  </other_outcome>
  <other_outcome>
    <measure>Brief Illnness Perception Questionnaire (BIPQ)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>individual concept of illness; 8 items, min 0, max 80, higher scores indicating worse illness perception</description>
  </other_outcome>
  <other_outcome>
    <measure>Brief Illnness Perception Questionnaire (BIPQ)</measure>
    <time_frame>twelve months</time_frame>
    <description>individual concept of illness; 8 items, min 0, max 80, higher scores indicating worse illness perception</description>
  </other_outcome>
  <other_outcome>
    <measure>Treatment Expectation Questionnaire (TEX-Q)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment</description>
  </other_outcome>
  <other_outcome>
    <measure>Treatment Expectation Questionnaire (TEX-Q)</measure>
    <time_frame>three months</time_frame>
    <description>treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment</description>
  </other_outcome>
  <other_outcome>
    <measure>Treatment Expectation Questionnaire (TEX-Q)</measure>
    <time_frame>twelve months</time_frame>
    <description>treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient Health Questionnaire-9 (PHQ-9)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient Health Questionnaire-9 (PHQ-9)</measure>
    <time_frame>three months</time_frame>
    <description>depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient Health Questionnaire-9 (PHQ-9)</measure>
    <time_frame>twelve months</time_frame>
    <description>depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>Generalized Anxiety Disorder-2 (GAD-2)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation), three and twelve months</time_frame>
    <description>anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>Generalized Anxiety Disorder-2 (GAD-2)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>Generalized Anxiety Disorder-2 (GAD-2)</measure>
    <time_frame>three months</time_frame>
    <description>anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>Cardiac Anxiety Questionnaire (CAQ)</measure>
    <time_frame>twelve months</time_frame>
    <description>cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety</description>
  </other_outcome>
  <other_outcome>
    <measure>Life Orientation Test - revised (LOT-R)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>optimism; 10 items, min 0, max 24, higher scores indicating higher optimism</description>
  </other_outcome>
  <other_outcome>
    <measure>Somatic Symptom Scale-8 (SSS-8)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden</description>
  </other_outcome>
  <other_outcome>
    <measure>Somatic Symptom Scale-8 (SSS-8)</measure>
    <time_frame>three months</time_frame>
    <description>somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden</description>
  </other_outcome>
  <other_outcome>
    <measure>Somatic Symptom Scale-8 (SSS-8)</measure>
    <time_frame>twelve months</time_frame>
    <description>somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden</description>
  </other_outcome>
  <other_outcome>
    <measure>Somatic Symptom Disorder - B Criteria Scale (SSD-12)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>Somatic Symptom Disorder - B Criteria Scale (SSD-12)</measure>
    <time_frame>three months</time_frame>
    <description>coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>Somatic Symptom Disorder - B Criteria Scale (SSD-12)</measure>
    <time_frame>twelve months</time_frame>
    <description>coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>International Physical Activity Questionnaire Short Form (IPAQ)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>level of physical activity</description>
  </other_outcome>
  <other_outcome>
    <measure>International Physical Activity Questionnaire Short Form (IPAQ)</measure>
    <time_frame>twelve months</time_frame>
    <description>level of physical activity</description>
  </other_outcome>
  <other_outcome>
    <measure>Hand Dynamometer</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>hand grip strength</description>
  </other_outcome>
  <other_outcome>
    <measure>Hand Dynamometer</measure>
    <time_frame>twelve months</time_frame>
    <description>hand grip strength</description>
  </other_outcome>
  <other_outcome>
    <measure>1 Minute Sit to Stand Test (1STS)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>physical capacity expressed with the number of repetitions</description>
  </other_outcome>
  <other_outcome>
    <measure>1 Minute Sit to Stand Test (1STS)</measure>
    <time_frame>twelve months</time_frame>
    <description>physical capacity expressed with the number of repetitions</description>
  </other_outcome>
  <other_outcome>
    <measure>Timed Up and Go (TUG)</measure>
    <time_frame>day of discharge (approx. 5 - 10 days after operation)</time_frame>
    <description>physical capacity expressed with the duration in seconds</description>
  </other_outcome>
  <other_outcome>
    <measure>Timed Up and Go (TUG)</measure>
    <time_frame>twelve months</time_frame>
    <description>physical capacity expressed with the duration in seconds</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">186</enrollment>
  <condition>Heart Valve Diseases</condition>
  <arm_group>
    <arm_group_label>ERAS protocol (intervention group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The innovative care process in the intervention group is characterized by an interdisciplinary approach according to the previously established enhanced recovery after surgery protocol. This process aims at improving the clinical outcome after cardiac surgery, increasing patient satisfaction and quality of life, enabling early professional reentry and participation, and optimizing the cost-effectiveness of service provision. In addition, intersectoral barriers are being broken down in order to establish an interdisciplinary and cross-sectoral overall care process for patients with heart valve surgery as a new form of care in the future.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as usual (control group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group undergoes standard heart valve surgery. In this case, no preoperative interventions take place, the patient is operated on the affected heart valve in a minimally invasive procedure without prehabilitation. After surgery, the patient is transfered to an intensive care unit (not a specialized postanesthesia care unit) depending on the individual condition and then transfered to the general ward. Patients receive medical, nursing, and physiotherapeutic care in accordance with current hospital standards.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enhanced Recovery After Surgery</intervention_name>
    <description>Enhanced recovery after surgery is a multimodal, transdisciplinary care approach for patients undergoing surgical procedures. It is implemented in various surgical specialties, among others in cardiac surgery. The care approach aims at promotion of recovery of the patients throughout their perioperative process, reduction of complications, and early return to normal activities.</description>
    <arm_group_label>ERAS protocol (intervention group)</arm_group_label>
    <other_name>fast track</other_name>
    <other_name>rapid recovery</other_name>
    <other_name>ERAS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment as Usual</intervention_name>
    <description>treatment as usual according to standard care in heart valve surgery</description>
    <arm_group_label>Treatment as usual (control group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Indication for elective minimally invasive (open) aortic or mitral valve surgery&#xD;
&#xD;
          -  Patient's ability to understand the nature and extent of the individual's requirements&#xD;
             for participation in the new care setting&#xD;
&#xD;
          -  Classification of the patient as &quot;FIT&quot; or &quot;Pre-FRAIL&quot; using the LUCAS functional index&#xD;
             (frailty index) (Dapp et al. 2012)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Limited life expectancy less than one year (e.g., advanced tumor disease)&#xD;
&#xD;
          -  Urgent or emergency interventions&#xD;
&#xD;
          -  Severe comorbidities or psychosocial reasons that militate against participation or do&#xD;
             not allow for written informed consent&#xD;
&#xD;
          -  Lack of a social environment that can provide supportive patient care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evaldas Girdauskas, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evaldas Girdauskas, Prof.</last_name>
    <phone>+49 821 400 2671</phone>
    <email>herzchirurgie@uk-augsburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jelena Bagnjuk, MSc</last_name>
    <phone>+ 49 40 7410 58685</phone>
    <email>j.bagnjuk@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <state>Bavaria</state>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Evaldas Girdauskas, Prof.</last_name>
      <phone>+49 821 400 2671</phone>
      <email>herzchirurgie@uk-augsburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jelena Bagnjuk, MSc</last_name>
      <phone>+ 49 40 7410 58685</phone>
      <email>j.bagnjuk@uke.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://innovationsfonds.g-ba.de/projekte/neue-versorgungsformen/increase-interdisziplinaere-und-sektorenuebergreifende-versorgung-in-der-herzchirurgie-am-beispiel-von-minimal-invasiven-herzklappeneingriffen.377</url>
    <description>summary of the project on the sponsor's website</description>
  </link>
  <reference>
    <citation>Kubitz JC, Schulte-Uentrop L, Zoellner C, Lemke M, Messner-Schmitt A, Kalbacher D, Sill B, Reichenspurner H, Koell B, Girdauskas E. Establishment of an enhanced recovery after surgery protocol in minimally invasive heart valve surgery. PLoS One. 2020 Apr 9;15(4):e0231378. doi: 10.1371/journal.pone.0231378. eCollection 2020.</citation>
    <PMID>32271849</PMID>
  </reference>
  <reference>
    <citation>Petersen J, Kloth B, Konertz J, Kubitz J, Schulte-Uentrop L, Ketels G, Reichenspurner H, Girdauskas E. Economic impact of enhanced recovery after surgery protocol in minimally invasive cardiac surgery. BMC Health Serv Res. 2021 Mar 20;21(1):254. doi: 10.1186/s12913-021-06218-5.</citation>
    <PMID>33743698</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 18, 2021</study_first_submitted>
  <study_first_submitted_qc>July 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Evaldas Girdauskas</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>randomized controlled trial</keyword>
  <keyword>enhanced recovery after surgery</keyword>
  <keyword>minimally invasive surgery</keyword>
  <keyword>postanesthesia care unit</keyword>
  <keyword>physiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

